Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2
Study is designed to evaluate the safety and tolerability of increasing dose levels of the
NEWCASTLE ANNOUNCES LIFE SCIENCE INVESTOR OPPORTUNITY TO GROW SECTOR AND CREATE JOBS
Newcastle City Council is looking for an investor to accelerate the growth of the region's
North East Innovation Lab achieves UKAS accreditation in recognition of its high standards
The North East Innovation Lab, part of Newcastle Hospitals has achieved a major milestone with
Atelerix Limited – Strategic partnership for market expansion
Atelerix Limited, which develops and markets innovative solutions for the storage and transport of cells,
CellRev appoint former Quorn Foods and ICI Executive to the board.
Technology disrupter CellRev have appointed Ralph Pickles, former executive at ICI, CEO of Quorn Foods,
Alcyomics® to Transform Drug Discovery for Osteoarthritis Treatment With Unique In Vitro Bio-Printed 3D Tissue Model.
Alcyomics Limited® announces it is seeking partners toparticipate in validation tests of its unique in
North east innovation lab celebrates two year anniversary supporting the development of cutting-edge diagnostics.
Based at The Biosphere in Newcastle Helix, the facility is part of Newcastle Hospitals and
Case study: North East Innovation Lab
Launched at the height of the pandemic in January 2021, the North East Innovation Lab,
Case study: AMLo Biosciences
Based in The Biosphere since September 2020, AMLo Biosciences is a spin out company from
Case Study: Iksuda Therapeutics
Founded in 2007 at Bath University as Glythera, Iksuda Therapeutics is an emerging biotechnology company